The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Capital Medical University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Capital Medical University
ClinicalTrials.gov Identifier:
NCT01236677
First received: November 8, 2010
Last updated: December 13, 2010
Last verified: August 2010
  Purpose

In the 21st century, threats to human health of new respiratory infectious diseases increased.

The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution.


Condition
Community Acquired Pneumonia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing

Resource links provided by NLM:


Further study details as provided by Capital Medical University:

Primary Outcome Measures:
  • Time to resolution of all symptoms (defined as the period from start of study-drug to relief of fever) [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • If duration of symptoms long, follow-up 30 days. [ Time Frame: one year ] [ Designated as safety issue: No ]
  • In case of early termination:death;diagnosed tuberculosis;diagnosed lung cancer and HIV infection [ Time Frame: one year ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

sputum,serum,and throat swabs


Estimated Enrollment: 1100
Study Start Date: August 2010
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Community acquired pneumonia,age≥14 ys
Patients with community acquired pneumonia,age≥14 ys and less than one week after the onset of symptoms, without pregnancy,breast-feeding,HIV infection,recent 90-day hospitalized history and in nursing homes or rehabilitation hospitals

  Eligibility

Ages Eligible for Study:   14 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Confirmed community acquired pneumonia

Criteria

Inclusion Criteria:

  1. Confirmed community acquired pneumonia
  2. Age≥14 ys
  3. New appear of cough or cough become severe
  4. New infiltration showed by chest radiology(x-ray or CT)
  5. Fever T>37.8o C or <35.6o C
  6. White blood cell>10,000/mm3 , left shift or leukopenia<4000/ul)

Exclusion Criteria:

  1. Pregnancy or breast-feeding
  2. Over one week after the onset of symptoms
  3. HIV infection
  4. Recent 90-day hospitalized history(length of stay greater than 2 days)
  5. Live in nursing homes or rehabilitation hospitals
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01236677

Contacts
Contact: Bin Cao, Doctor 86-010-85231167 caobin1999@gmail.com
Contact: Li Gu, Doctor 86-010-85231514 guliangel@yahoo.com.cn

Locations
China, Beijing
Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute Recruiting
Beijing, Beijing, China, 100020
Contact: Bin Cao, Doctor    86-010-85231167    caobin1999@gmail.com   
Sponsors and Collaborators
Capital Medical University
Investigators
Study Chair: Chen Wang, Doctor Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute
  More Information

No publications provided

Responsible Party: Chen Wang, Capital Medical University Affiliated Beijing Chaoyang Hospital
ClinicalTrials.gov Identifier: NCT01236677     History of Changes
Other Study ID Numbers: xfcrb123456
Study First Received: November 8, 2010
Last Updated: December 13, 2010
Health Authority: China: Beijing Municipal Science and Technology Commission

Keywords provided by Capital Medical University:
Pathogen

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on September 22, 2014